Dr. Jessica Mann, MD, PhD is a cardiologist with long-standing experience in the cardiovascular and metabolic drug development arena; in particular as Medical Director and member of the Management group at Speedel, which has recently been sold to Novartis for $880 million. Before joining Speedel, Jessica worked for Roche and Novartis.
